Test Expands Labcorp’s Leadership In Bringing Testing Solutions for New Precision Medicines Used to Treat Patients With Lung Cancer BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp ® (NYSE: LH), a leading ...

Test Expands Labcorp’s Leadership In Bringing Testing Solutions for New Precision Medicines Used to Treat Patients With Lung Cancer Photo courtesy of Labcorp. Labcorp’s oncology platform brings ...

Laboratory Corporation Of America Holdings (NYSE:LH) acquires certain operations of Opko Health, Inc‘s (NASDAQ:OPK) subsidiary BioReference Health. The assets Labcorp is acquiring generate about $100 ...

Diagnostics giant Labcorp is stepping deeper into the digital health space with the launch of Labcorp OnDemand, an online platform where users can order tests and possibly collect samples at home.

Editor’s note: LimeLight is a new feature from WRAL TechWire offering another means of publishing noteworthy news. Be sure to check out more LimeLight worthy news at this link. BURLINGTON — Labcorp ...

BD is pairing up with Labcorp to develop a new line of companion diagnostics for cancer treatments and therapies for other diseases, analyzing patients’ cells using flow cytometry technology to match ...

Labcorp Holdings Inc. LH, or Labcorp, is slated to report its first-quarter 2025 results on April 29, before the opening bell. The renowned laboratory service provider reported adjusted earnings of $3 ...

CEO Adam Schechter highlighted a 5% revenue growth for Q1 2025, with Diagnostics Laboratories achieving a 6% increase. This growth was attributed to rebounding volumes and strong managed care access.

For the full fiscal year 2025, Wall Street analysts expect Labcorp’s diluted EPS to grow by 12% annually to $16.32, followed ...

The FDA has bestowed a green light to a companion diagnostic for Pfizer’s recently approved hemophilia B gene therapy—because, at a cost of $3.5 million per dose, you want to make sure it will work.

BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (LabCorp®) (NYSE:LH), a leading global life sciences company, today announced that Gary Huff is being promoted to CEO of ...